Pro-embryonic Stem Cell Research Journal Warns of Hype

The British medical journal, The Lancet, is attempting to mute the sensationalist claims of our having miracle cures just around the corner. That therapies derived from embryonic stem cell research are unlikely to be availabe in less than a decade is not news to those who follow this issue closely and are aware of "[t]he natural propensity of embryonic stem cells to form [tumors], their exhibition of chromosomal abnormalities, and abnormalities in cloned mammals." And for those who don't think such future therapies will require a Brave New World-like production and cost efficiency mentality that is based on the destruction of millions of humans, there is this:

"To treat, for example, the 17 million diabetes patients in the United States will require a minimum of 850 million to 1.7 billion human eggs," molecular and cellular pharmacologist and patent attorney, Dr. Kelly Hollowell said. "Collecting 10 eggs per donor will require a minimum of 85 to 170 million women."

"The total cost would be astronomical, at $100,000 to $200,000 for 50 to 100 human eggs per each patient," Dr. Hollowell explained.